Dexmedetomidine bulk supplier for pharma manufacturers

Dexmedetomidine 100 mcg/mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Infusion/Injection

Available Strengths: 100 mcg/mL

Reference Brands: Precedex(US); Dexdor(EU)

Dexmedetomidine is a sedation agent used in ICUs and surgeries, available as 100 mcg/mL concentrate and 4 mcg/mL ready-to-use infusions. Brands include Precedex, Dexdor, and Accord. It’s a key anesthetic product in pharma B2B hospital procurement, widely used for conscious sedation and ventilated patient care.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Dexmedetomidine is a highly selective alpha-2 adrenergic agonist used for sedation in ICU and surgical settings without causing respiratory depression. Available as a 100 mcg/mL concentrate in 2 mL and 4 mL vials, and as ready-to-use infusions (4 mcg/mL in 50 mL and 100 mL), it ensures flexible dosing and efficient workflow. In the US, Precedex by Pfizer and generic alternatives are widely used. The EU features Dexdor (Orion), Accord, and B. Braun formulations. Dexmedetomidine is a critical care drug frequently procured via pharma B2B platforms for operating rooms, ICUs, and procedural sedation in institutional healthcare settings.

Dexmedetomidine — third party manufacturing & bulk supply

Dexmedetomidine 100 mcg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dexmedetomidine is supplied as Intravenous (IV) Infusion/Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dexmedetomidine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dexmedetomidine →

Back to Listing

Frequently Asked Questions

Dexmedetomidine injection is used for sedation of initially intubated and mechanically ventilated patients in intensive care units. It is also used for procedural sedation in non-intubated patients before or during surgical and diagnostic procedures. It provides sedation with minimal respiratory depression.

Dexmedetomidine injection is made from dexmedetomidine hydrochloride. It is a selective alpha-2 adrenergic receptor agonist that produces sedative and analgesic effects by reducing sympathetic nervous system activity.

The most well-known trade name is Precedex.

Precedex was originally developed and marketed by Hospira. It is now marketed by Pfizer in many countries. Generic dexmedetomidine injection is also manufactured by multiple pharmaceutical companies worldwide.

The generic name is dexmedetomidine hydrochloride.

The brand name is Precedex.

Dexmedetomidine injection is manufactured in GMP-certified pharmaceutical facilities in the United States, Europe, India, and other regulated markets depending on the marketing authorization holder and supplier. Specific manufacturing sites vary by brand and batch.